Divi s Laboratories Limited at its board meeting, held on May 25, 2024, Recommended a final dividend of INR 30/- per equity share of face value INR 2/- each for the financial year 2023-24, subject to.
Divi s Laboratories Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 23,030 million compared to INR 19,510.
Divi s Laboratories Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 78,450 million compared to INR 77,670 million a year.
Presentation Operator MessageOperator Ladies and gentlemen, good day, and welcome to the earnings conference call of Divi s Laboratories Limited for Q4 FY 2024. As a reminder, all participant lines.
Which Is The Largest Pharma Company In India | Top 10 Pharmaceutical Companies By Market Cap In India forbesindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbesindia.com Daily Mail and Mail on Sunday newspapers.